| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |